• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Certara Inc (NQ: CERT )

    17.11 +0.03 (+0.18%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Apr 30, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 463,977
    Open 16.89
    Bid (Size) 16.08 (1)
    Ask (Size) 18.00 (56)
    Prev. Close 17.08
    Today's Range 16.85 - 17.34
    52wk Range 11.81 - 24.64
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Certara Launches Cloud Platform to Further Unify its End-to-End Scientific Software Platform
    From Certara
    Via GlobeNewswire
    Certara to Report First Quarter 2024 Financial Results on May 7th, 2024 and Participate in the BofA Securities Healthcare Conference
    From Certara
    Via GlobeNewswire

    Performance

    YTD
    -1.38%
    -1.38%
    1 Month
    -4.94%
    -4.94%
    3 Month
    +4.27%
    +4.27%
    6 Month
    +40.36%
    +40.36%
    1 Year
    -30.56%
    -30.56%

    More News

    Read More
    Decoding 4 Analyst Evaluations For Certara
    Via Benzinga
    Analyst Scoreboard: 4 Ratings For Certara
    Via Benzinga
    Certara Reports Fourth Quarter 2023 Financial Results
    From Certara
    Via GlobeNewswire
    Earnings Scheduled For February 29, 2024
    Via Benzinga
    Recap: Certara Q3 Earnings
    Via Benzinga
    The Latest Analyst Ratings for Certara
    Via Benzinga
    Certara to Report Fourth Quarter and Full Year 2023 Financial Results on February 29th, 2024 and Participate in the Barclays 26th Annual Global Healthcare Conference
    From Certara
    Via GlobeNewswire
    Tax Season Is Here: Meet The New Federal Program That Can Eat Away At Tax Preparation Companies
    Via Benzinga
    Certara Acquires Applied BioMath Expanding Its Biosimulation Portfolio to Industrialize New Capabilities for Optimal Dosing for Novel Therapies
    From Certara
    Via GlobeNewswire
    The Latest Analyst Ratings for Certara
    Via Benzinga
    Looking Into Certara's Return On Capital Employed
    Via Benzinga
    Certara introduces Simcyp™ Biopharmaceutics software to increase efficiency of novel and generic drug formulation & development
    From Certara
    Via GlobeNewswire
    Certara Reports Third Quarter 2023 Financial Results
    From Certara
    Via GlobeNewswire
    Certara to Report Third Quarter 2023 Financial Results on November 8th, 2023, and participate in the Stephens Annual Investment Conference
    From Certara
    Via GlobeNewswire
    Certara Announces 300th Regulatory Submission Milestone Using its Technology-enabled Services and Software
    From Certara
    Via GlobeNewswire
    Certara to Participate in Upcoming Investor Conferences
    From Certara
    Via GlobeNewswire
    Certara Simcyp™ Group Awarded Two New Grants from US FDA
    From Certara
    Via GlobeNewswire
    Benzinga's Top Ratings Upgrades, Downgrades For August 22, 2023
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For August 10, 2023
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    Certara Reports Second Quarter 2023 Financial Results
    From Certara
    Via GlobeNewswire
    Certara to Report Second Quarter 2023 Financial Results on August 9th, 2023
    From Certara
    Via GlobeNewswire
    Certara to Participate in the Jefferies Global Healthcare Conference
    From Certara
    Via GlobeNewswire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.